A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma

BACKGROUND: To explore the feasibility and safety of natural killer (NK) cell therapy in HCC, we performed a prospective, open-label, phase I trial to evaluate the synergistic effect of locoregional high-dose autologous NK cell therapy in combination with hepatic arterial infusion chemotherapy (HAIC...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Woo Kyun, Lee, Byung Chan, Kim, Hyeon-Jong, Lee, Je-Jung, Chung, Ik-Joo, Cho, Sung Bum, Koh, Yang Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202498/
https://www.ncbi.nlm.nih.gov/pubmed/35720374
http://dx.doi.org/10.3389/fimmu.2022.879452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202498/
https://www.ncbi.nlm.nih.gov/pubmed/35720374
http://dx.doi.org/10.3389/fimmu.2022.879452

Ejemplares similares